UBS Upgrades Celestica to Buy, Raises Price Target to $430
Benzinga Newsdesk 2 months ago
NewsUpgradesAnalyst RatingsPrice Target
UBS analyst David Vogt upgrades Celestica (NYSE:CLS) from Neutral to Buy and raises the price target from $410 to $430.
UBS analyst David Vogt upgrades Celestica (NYSE:CLS) from Neutral to Buy and raises the price target from $410 to $430.